A new blood test, called TriOx, has shown promising results in detecting several types of cancer in their early stages.

The TriOx test, developed by researchers at the University of Oxford, uses a liquid biopsy to analyze DNA in the blood and detect subtle signs of cancer. It has accurately identified cancer, including in its early stages, in six types of cancer. The test has the potential to improve survival rates for millions of people by allowing cancer to be detected earlier.